The effect of the CEBPA mutation was more pronounced in distal elements (observed 79.3% and 75.9% differential peaks, in MDS-High and Low risk, respectively, compared to 59.6% in all peaks; Chi-square p-value 5.4E−14) than in promoter regions (Fig. 6D). This evidence concerns the gene CEBPA and myelodysplastic syndrome.